Christophe Weber
President and CEO
Replay available
Takeda Pharmaceutical Company Limited (TAK) Q1 2025 Earnings Call
Takeda Pharmaceutical Company Limited (NYSE: TAK) Q1 2025 earnings conference call, held 2025-07-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Andy Plump
President of R&D
Julie Kim
U.S. Business Union President
Steve Barker
Analyst, Jefferies
Michael Nedeljkovic
Analyst, TD Cowen
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Takeda Pharmaceutical Co. Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.240 Thank you for joining us for FY25Q1 00:00:06.240 -- 00:00:10.707 earnings announcement by Takeda, despite your very busy schedule today. 00:00:10.707 -- 00:00:13.291 I'm the 00:00:13.291 -- 00:00:15.915 master of the ceremony, head of AYA. 00:00:15.915 -- 00:00:18.118 My name is O'Reilly. Thank you for this opportunity. 00:00:18.118 -- 00:00:23.086 And I would like to explain about the language setting to begin with. 00:00:23.086 -- 00:00:27.537 Please find the language selection button at the bottom of your Zoom window. 00:00:27.537 -- 00:00:31.343 If you wish to listen in Japanese, please select the Japanese channel. 00:00:31.343 -- 00:00:34.288 If English, please choose the English channel. 00:00:34.288 -- 00:00:39.236 And if you want to listen to the original, please turn it off. 00:00:39.236 -- 00:00:43.703 For those of you who wish to listen to this call in English, please select English in 00:00:43.703 -- 00:00:47.065 the Zoom language select button. 00:00:47.469 -- 00:00:49.469 本日のコールでは米国の1995年 00:00:51.584 -- 00:00:55.068 Before starting, I'd like to remind everyone that we'll be discussing forward-looking 00:00:55.068 -- 00:00:59.712 statements with the meaning of the Private Securities Litigation Reforms Act of 1995. 00:00:59.712 -- 00:01:01.712 Actual 00:01:03.777 -- 00:01:08.299 results may differ materially from those discussed today. 00:01:08.361 -- 00:01:12.786 The factors that could cause our actual results to differ materially are discussed in 00:01:12.786 -- 00:01:19.230 our most recent Form 20F and in our other SEC findings. 00:01:25.722 -- 00:01:30.967 Please also refer to the important notice on page two of the presentation regarding forward-looking 00:01:30.967 -- 00:01:35.992 statements, non-IFRS financial m...